TPB insider sells 46,470 shares; post-sale holdings 280,368
Rhea-AI Filing Summary
Turning Point Brands (TPB) reported insider activity by a director, who sold common stock over three consecutive days. On 11/11/2025, the director sold 15,000 shares at a weighted average price of $99.89. On 11/12/2025, 21,069 shares were sold at a weighted average price of $100.02. On 11/13/2025, 10,401 shares were sold at a weighted average price of $99.03. The reported prices reflect multiple trades within disclosed ranges.
Following the transactions, beneficial ownership reported in Column 5 progressed to 315,186, then 290,765, and finally 280,368 shares, all held directly. The filing also lists outstanding stock options with various exercise prices and expirations under the company’s equity plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 10,401 | $99.03 | $1.03M |
| Sale | Common Stock | 21,069 | $100.02 | $2.11M |
| Sale | Common Stock | 15,000 | $99.89 | $1.50M |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
Footnotes (12)
- F1. The options vest and become exercisable as to 34% of the underlying shares on January 1, 2018, 33% of the underlying shares on January 1, 2019 and 33% of the underlying shares on January 1, 2020.
- F2. The options vest and become exercisable as to 34% of the underlying shares on January 1, 2019, 33% of the underlying shares on January 1, 2020 and 33% of the underlying shares on January 1, 2021.
- F3. Granted pursuant to the issuer's 2015 Equity Incentive Plan.
- F4. The options vest and become exercisable as to 34% of the underlying shares on January 1, 2020, 33% of the underlying shares on January 1, 2021 and 33% of the underlying shares on January 1, 2022.
- F5. The options vest and become exercisable as to 34% of the underlying shares on January 1, 2021, 33% of the underlying shares on January 1, 2022 and 33% of the underlying shares on January 1, 2023.
- F6. The options vest and become exercisable as to 34% of the underlying shares on January 1, 2022, 33% of the underlying shares on January 1, 2023 and 33% of the underlying shares on January 1, 2024.
- F7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.43 to $101.33.
- F8. The total reported in Column 5 includes 3,352 restricted stock units and 311,834 shares of common stock.
- F9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.05 to $101.27.
- F10. The total reported in Column 5 includes 3,352 restricted stock units and 290,765 shares of common stock.
- F11. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.25 to $100.05.
- F12. The total reported in Column 5 includes 3,352 restricted stock units and 280,364 shares of common stock.
AI-generated analysis. How Rhea-AI works. Not financial advice.